Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics

References

• Collaborators GDaIIaPGlobal, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet201638810053154527733282
   PubMed Web of Science ®Google Scholar
• Health TNIoM [webpage on the Internet]Depression2016 Available from: https://www.nimh.nih.gov/health/topics/depression/index.shtmlAccessed December 28, 2017
   Google Scholar
• SalomonJAVosTHoganDRCommon values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010Lancet20123809859212923245605
   PubMed Web of Science ®Google Scholar
• KlineERSeidmanLJCornblattBADepression and clinical high-risk states: baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohortSchizophr Res201719235736328578922
   PubMed Web of Science ®Google Scholar
• SubramaniamMAbdinESeowELPiccoLVaingankarJAChongSASuicidal ideation, suicidal plan and suicidal attempts among those with major depressive disorderAnn Acad Med Singapore201443841242125244990
   PubMed Web of Science ®Google Scholar
• OharaMWOxford Handbook of Depression and ComorbidityOxford, EnglandOxford University Press2014
   Google Scholar
• RuhéHGMasonNSScheneAHMood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studiesMol Psychiatry200712433117389902
   PubMed Web of Science ®Google Scholar
• KöhlerOBenrosMENordentoftMEffect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trialsJAMA Psychiatry201471121381139125322082
   PubMed Web of Science ®Google Scholar
• PhillipsLJMcgorryPDGarnerBStress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disordersAust N Z J Psychiatry200640972574116911747
   PubMed Web of Science ®Google Scholar
• LeniculescuHKurianSMYehyawiNIdentifying blood biomarkers for mood disorders using convergent functional genomicsMol Psychiatry200914215617418301394
   PubMed Web of Science ®Google Scholar
• YangYYangDTangGProteomics reveals energy and glutathione metabolic dysregulation in the prefrontal cortex of a rat model of depressionNeuroscience20132471319120023727007
   PubMed Web of Science ®Google Scholar
• PengZYingWLiangCIdentification and validation of urinary metabolite biomarkers for major depressive disorderMol Cell Proteomics201312120723111923
   PubMed Web of Science ®Google Scholar
• SnyderMMiasGStanberryLKolkerEMetadata checklist for the integrated personal OMICS study: proteomics and metabolomics experimentsOMICS2014181818524456466
   PubMed Web of Science ®Google Scholar
• MaYZhangPWangFLiuWYangJQinHAn integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancerAnn Surg2012255472022395091
   PubMed Web of Science ®Google Scholar
• MayrMYusufSWeirGCombined metabolomic and proteomic analysis of human atrial fibrillationJ Am Coll Cardiol200851558518237690
   PubMed Web of Science ®Google Scholar
• FiliouMDZhangYTeplytskaLProteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathwaysBiol Psychiatry201170111074108221791337
   PubMed Web of Science ®Google Scholar
• ShaoWHChenJJFanSHCombined metabolomics and proteomics analysis of major depression in an animal model: perturbed energy metabolism in the chronic mild stressed rat cerebellumOMICS201519738326134254
   PubMed Web of Science ®Google Scholar
• LiuXZhengPZhaoXDiscovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometryJ Proteome Res20151452322233025784130
   PubMed Web of Science ®Google Scholar
• UherRPayneJLPavlovaBPerlisRHMajor depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IVDepress Anxiety201431645947124272961
   PubMed Web of Science ®Google Scholar
• WisniewskiJZougmanANagarajNMannMUniversal sample preparation method for proteome analysisNat Methods20096535936219377485
   PubMed Web of Science ®Google Scholar
• XuHBZhangRFLuoDComparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulationInt J Neuropsychopharmacol20121510141322717272
   PubMed Web of Science ®Google Scholar
• HanXShaoWLiuZiTRAQ-based quantitative analysis of hippocampal postsynaptic density-associated proteins in a rat chronic mild stress model of depressionNeuroscience201529822025862978
   PubMed Web of Science ®Google Scholar
• RenYHaoPDuttaBHypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studiesMol Cell Proteomics201312248523204318
   PubMed Web of Science ®Google Scholar
• LiuYYZhouXYYangLNSocial defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of ratsPLoS One2017124e017672528453574
   PubMed Web of Science ®Google Scholar
• YangCZhouCLiJQuantitative proteomic study of the plasma reveals acute phase response and LXR/RXR and FXR/RXR activation in the chronic unpredictable mild stress mouse model of depressionMol Med Rep20171719310229115597
   PubMed Web of Science ®Google Scholar
• EdwardsPAKennedyMAMakPALXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasisVascul Pharmacol200238424925612449021
   PubMed Web of Science ®Google Scholar
• LiuLZhouXZhangYThe identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depressionBehav Brain Res201630514826947756
   PubMed Web of Science ®Google Scholar
• WuYTangJZhouCQuantitative proteomics analysis of the liver reveals immune regulation and lipid metabolism dysregulation in a mouse model of depressionBehav Brain Res201631133033927247144
   PubMed Web of Science ®Google Scholar
• CataniMVGasperiVBisognoTMaccarroneMEssential dietary bioactive lipids in neuroinflammatory diseasesAntioxid Redox Signal Epub2017 724
   Web of Science ®Google Scholar
• FarmerKSmithCAHayleySSmithJMajor alterations of phosphatidylcholine and lysophosphotidylcholine lipids in the substantia nigra using an early stage model of Parkinson’s diseaseInt J Mol Sci2015168188651887726274953
   PubMed Web of Science ®Google Scholar
• van denEPGargSLeónLApolipoprotein-mediated pathways of lipid antigen presentationNature2005437706090616208376
   PubMed Web of Science ®Google Scholar
• ZhangHWuJZhuJThe role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritisJ Biomed Biotechnol201020101110–724335741220182542
   PubMedGoogle Scholar
• Braesch-AndersenSPaulieSSmedmanCMiaSKumagai-BraeschMApoE production in human monocytes and its regulation by inflammatory cytokinesPLoS One2013811e7990824244577
   PubMed Web of Science ®Google Scholar
• ZhangZMuJLiJLiWSongJAberrant apolipoprotein E expression and cognitive dysfunction in patients with poststroke depressionGenet Test Mol Biomarkers2013171475123171142
   PubMed Web of Science ®Google Scholar
• ShimanoHYamadaNKatsukiMOverexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemiaProc Natl Acad Sci U S A199289517501542669
   PubMed Web of Science ®Google Scholar
• RibasVSánchez-QuesadaJLAntónRHuman apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potentialCirc Res200495878979715388641
   PubMed Web of Science ®Google Scholar
• VaisarTPennathurSGreenPSShotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDLJ Clin Invest2007117374617332893
   PubMed Web of Science ®Google Scholar
• TakahashiYChibaHMatsunoKNative lipoproteins inhibit platelet activation induced by oxidized lipoproteinsBiochem Biophys Res Commun199622224534598670226
   PubMed Web of Science ®Google Scholar
• KellerJNSteinerMRHoltsbergFWMattsonMPSteinerSMLysophosphatidic acid-induced proliferation-related signals in astrocytesJ Neurochem1997693107310849282930
   PubMed Web of Science ®Google Scholar
• XaioHBanksWANiehoffMLMorleyJEEffect of LPS on the permeability of the blood-brain barrier to insulinBrain Res20018961–23611277970
   PubMed Web of Science ®Google Scholar
• SheltonRCClaiborneJSidorykwegrzynowiczMAltered expression of genes involved in inflammation and apoptosis in frontal cortex in major depressionMol Psychiatry201116775176220479761
   PubMed Web of Science ®Google Scholar
• MiHMuruganujanACasagrandeJTThomasPDLarge-scale gene function analysis with the PANTHER classification systemNat Protoc2013881551156623868073
   PubMed Web of Science ®Google Scholar